Loading...

ONCOTELIC THERAPEUTICS INC Company Mergers 8-K Filing

NCTL

ONCOTELIC THERAPEUTICS INC

()

2026 8-K

Joint Development Agreement

Product Launch Announcement

Research Presentation

Financing Agreement

Stock Agreement Details

Milestone Amendment

Contract Amendment

Funding Agreement Completed

Debt Financing Agreement

Access to Research Tools

Investment Offering Details

Investor Presentation Update

Equity Offerings

Presentation Announcement

External Links:

On December 31, 2025, Oncotelic Therapeutics, Inc. amended its agreement with Jefferson Capital Ventures, lowering the milestone market cap from $100 million to $45 million for stock awards.

AI Assistant

ONCOTELIC THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.